Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Conditions:   Recurrent Cervical Carcinoma;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Vaginal Carcinoma;   Stage IV Cervical Cancer AJCC v8;   Stage IV Fallopian Tube Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Primary Peritoneal Cancer AJCC v8;   Stage IV Uterine Corpus Cancer AJCC v8;   Stage IV Vaginal Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Fallopian Tube Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Primary Peritoneal Cancer AJCC v8;   Stage IVA Uterine Corpus Cancer AJCC v8;   Stage IVA Vaginal Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Fallopian Tube Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Primary Peritoneal Cancer AJCC v8;   Stage IVB Uterine Corpus Cancer AJCC v8;   Stage IVB Vaginal Cancer AJCC v8
Interventions:   Procedure: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Talazoparib
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 1, 2019 / by / in
Comments